| Literature DB >> 33047207 |
Gali Pariente1, Orit Wissotzky Broder2, Eyal Sheiner2, Talya Lanxner Battat2, Elad Mazor2, Shimrit Yaniv Salem2, Tamar Kosef3, Tamar Wainstock4.
Abstract
The aim of the current study was to assess the risk for post-partum depression among women delivering during the COVID-19 pandemic as compared to the risk among women delivering before the COVID-19 pandemic. A cohort study was performed among women delivering singletons at term which were recruited in the maternity wards of the Soroka University Medical Center. Recruitment was done during the COVID-19 strict isolation period (March 18 and April 29, 2020). Women delivering during the COVID-19 pandemic completed the Edinburgh Postnatal Depression Scale (EPDS), and the results were compared to women delivering at the same medical center before the COVID-19 pandemic. Multivariable logistic regression models were constructed to control for potential confounders. A total of 223 women who delivered during the COVID-19 strict isolation period were recruited. Women delivering during the COVID-19 pandemic had lower risk of having a high (> 10) or very high (≥ 13) EPDS score as compared with women delivering before the COVID-19 pandemic (16.7% vs 31.3%, p = 0.002, and 6.8% vs 15.2%, p = 0.014, for EPDS ≥ 10 and EPDS ≥ 13, respectively). These results remained similar in the multivariable logistic regression models, for both EPDS score ≥ 10 and EPDS score ≥ 13, while controlling for maternal age, ethnicity, marital status, and adverse pregnancy outcomes (adjusted OR 0.4, 95% CI 0.23-0.70, p = 0.001 and adjusted OR 0.3, 95% CI 0.15-0.74, p = 0.007 for EPDS score > 10 and > 13, respectively). In our population, delivering during the COVID-19 pandemic was independently associated with lower risk of post-partum depression.Entities:
Keywords: COVID-19; Depression; EPDS; Post-partum
Mesh:
Year: 2020 PMID: 33047207 PMCID: PMC7549733 DOI: 10.1007/s00737-020-01075-3
Source DB: PubMed Journal: Arch Womens Ment Health ISSN: 1434-1816 Impact factor: 3.633
Maternal demographic features and pregnancy outcomes of study population
| Characteristic | Delivery during the COVID-19 pandemic | Delivery before the COVID-19 pandemic | ||
|---|---|---|---|---|
| Maternal age, years (mean ± SD) | 29.1 ± 5.1 | 28.3 ± 5.0 | 0.816 | |
| Ethnicity | Jewish | 53.4 | 58.8 | 0.345 |
| Bedouins | 46.6 | 41.2 | ||
| Marital status | Married | 90.6 | 79.1 | 0.003 |
| Other | 9.4 | 20.9 | ||
| Gravidity | 1 | 16.1 | 19.1 | 0.779 |
| 2–4 | 57.0 | 55.7 | ||
| ≤ 5 | 26.9 | 25.2 | ||
| Parity | 1 | 24.7 | 24.3 | 0.001 |
| 2–4 | 42.6 | 60.9 | ||
| ≤ 5 | 32.7 | 14.8 | ||
| Fertility treatments | 3.1 | 7.0 | 0.106 | |
| Gestational diabetes mellitus | 4.0 | 5.0 | 0.708 | |
| Preeclampsia | 2.2 | 0.0 | 0.112 | |
| Newborn sex | Male | 49.7 | 50.4 | 0.766 |
| Female | 50.2 | 49.6 | ||
| Birth weight, g (mean ± SD) | 3297.3 ± 406.1 | 3273.4 ± 376.0 | 0.474 | |
| Gestational age at birth, weeks (mean ± SD) | 39.4 ± 1.0 | 39.4 ± 0.9 | 0.816 |
EPDS results among women in the immediate post-partum period delivering during and before the COVID-19 pandemic
| Delivery during the COVID-19 pandemic | Delivery before the COVID-19 pandemic | ||
|---|---|---|---|
| Total EPDS score ≥ 10 | 16.7 | 31.3 | 0.002 |
| Total EPDS score ≥ 13 | 6.8 | 15.2 | 0.014 |
| Suicidal ideations (according to question number 10 in EPDS questionnaire) | 0.5 | 0.9 | 0.621 |
Multivariable logistic regression models for the association between timing of delivery and EDPS score ≥ 10 and ≥ 13
| Model 1 | Model 2 | |||||
|---|---|---|---|---|---|---|
| Adjusted OR | 95%CI | Adjusted OR | 95%CI | |||
| Delivery during the COVID-19 pandemic (vs delivery before the COVID-19 pandemic) | 0.4 | 0.23–0.70 | 0.001 | 0.3 | 0.15–0.74 | 0.007 |
| Maternal age (years) | 1.0 | 1.00–1.12 | 0.023 | 1.1 | 1.05–1.23 | 0.001 |
| Ethnicity (Jewish vs. Bedouin) | 0.5 | 0.30–0.98 | 0.045 | 0.4 | 0.18–0.92 | 0.031 |
| Marital status (married vs not married) | 1.2 | 0.53–2.82 | 0.633 | 1.2 | 0.38–4.08 | 0.708 |
| Adverse pregnancy outcomes* | 0.9 | 0.28–2.95 | 0.889 | 0.3 | 0.04–3.26 | 0.391 |
*Adverse pregnancy outcomes include preeclampsia and gestational diabetes mellitus